SCHEMBL6670610

SCHEMBL6670610

CN1CCN(CCOCN(Cc2ccc(Cl)cc2)C(=O)c2c[nH]c3ccc(CN4CCOCC4)cc3c2=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.42
KDM4E B2RXH2 5/20 0.42
HPGD P15428 5/20 0.42
GAA P10253 2/20 0.42
GLA P06280 1/20 0.42
HTR2A P28223 1/20 0.41
HTR2B P41595 1/20 0.41
MAPT P10636 2/20 0.40
TSHR P16473 2/20 0.39
USP2 O75604 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
POLA1 P09884 2/20 0.38
HSD17B10 Q99714 2/20 0.38
HRH3 Q9Y5N1 1/20 0.38
MAPK14 Q16539 1/20 0.38
KCNH2 Q12809 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6701498 0.96 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL6669451 0.94 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL6670162 0.91 HTR2A (0.43) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL7847400 0.90 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL7845988 0.90 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL7843009 0.90 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL7848592 0.85 HRH3 (0.45) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL7848275 0.85 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL6667769 0.85 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL7846819 0.85 HTR2A (0.43) ALDH1A1KDM4EHPGDGAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004019932-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO claimed
WO-2004019932-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO disclosed